Toronto Dominion Bank’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Toronto Dominion Bank’s Portfolio VBIV Stock Details VBIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Hold	0	–	–	–	1442
2017 Q4	–	Sell	-3	Closed	-$369	–	1320
2017 Q3	$0	Hold	3	–	–	﹤0.01%	1257
2017 Q2	$0	Hold	3	–	–	﹤0.01%	1300
2017 Q1	$0	Buy	+3	New	+$406	﹤0.01%	1297
2016 Q4	–	Sell	-1	Closed	–	–	1322
2016 Q3	$0	Sell	1 -2	-67%	-$224	﹤0.01%	1270
2016 Q2	$0	Buy	+3	New	+$301	﹤0.01%	1321

Other funds holding VBIV

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

Clarus Ventures Cambridge, Massachusetts $425M AUM 26.13% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

MIH

Meitav Investment House Bene-Beraq, Israel $14.9B AUM 46.8% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Toronto Dominion Bank's VBIV Position: Q1 2018 in Review

Toronto Dominion Bank held its VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) position steady in Q1 2018 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1442.

Toronto Dominion Bank first reported a position in VBIV in Q2 2016 and has held it in 5 quarters since. The position peaked at $0 in Q3 2017. 60 funds tracked by Wall St. Rank hold VBIV as of Q1 2018.

Toronto Dominion Bank held 0 shares of VBI Vaccines, Inc. New Common Stock (Canada) worth $0 as of Q1 2018.
Toronto Dominion Bank left its VBI Vaccines, Inc. New Common Stock (Canada) share count unchanged in Q1 2018.
VBI Vaccines, Inc. New Common Stock (Canada) made up ﹤0.01% of Toronto Dominion Bank's portfolio in Q1 2018, its #1442 holding.
Toronto Dominion Bank first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q2 2016 and has held it in 5 quarters since.
Toronto Dominion Bank's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $0 in Q3 2017.
60 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q1 2018.

Based on Toronto Dominion Bank's 13F filing for Q1 2018, filed 10 May 2018.